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Shifting metaphors in direct-to-consumer genetic testing: From genes as information 
to genes as big data 
 
This article analyses shifts in metaphors in direct-to-consumer genetic testing, 
analysing the websites and select media coverage of the nutrigenetic testing 
company Sciona (2000-2009) and the personal genome service 23andMe (2006--). 
Sciona represented genes and communication through the classical metaphor of 
information; genes coded for disease, and this information was transmitted from the 
expert company to the consumers. 23andMe represented genes and communication 
through a new metaphor of big data; genes were digital data or a resource that was 
browsed, correlated with other data, uploaded and retrieved across lay customers, 
websites and companies. In terms of understanding health 23andMe tests and 
research still cast genes as coding for disease to be mitigated by lifestyle change 
and targeted drugs. However, rendering genes digital data or resources changed 
their social and economic meaning; genes could be circulated, shared and traded, 
which legitimised 23andMe’s business model of consumer genetics and private 
biobanking. 
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This article examines metaphors used by two direct-to-consumer (DTC) genetic 
testing companies; the nutrigenetic testing company Sciona (2000-2009) and 
23andMe, which doubles up as a consumer genetics company and private biobank 
with over one million (23andMe, 2015) DNA samples and customers (2006--). I will 
argue that the companies represented genes and communication between the 
company and its customers through the two distinct ontological metaphors of 
information and big data. 
 
There is a significant body of literature on metaphors used in science. It has been 
noted that scientists use metaphors to popularise their findings (Nelkin, 1994) but, as 
pointed out by Lakoff and Johnson (Lakoff & Johnson, 2008), metaphors are not 
innocent but typically legitimate specific agendas, such as bids for funding scientific 
projects, such as the Human Genome Project (Nerlich & Hellsten, 2004), or the 
creation of markets, such as the creation of data-driven markets for health 
(Ruckenstein & Pantzar, 2015). 
 
Nelkin’s classic analysis of metaphors of genes in science and popular culture 
argued that genes were frequently cast as the “master code,” which scientists could 
“decipher” and “read” to predict human “fates” as if through a “medical crystal ball” 
(Nelkin, 1994). The historical ramifications of this deterministic vision of genes as the 
“blueprint” or “book of life” was studied by Kay (Kay, 2000), who noted that the 
metaphor of information underpinning Francis Crick’s formulation of the “central 
dogma” in genetics according to which DNA codes for RNA, which codes for proteins 
originated from Shannon’s classical theory of communication (Shannon & Weaver, 
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1949). Shannon, an engineer in the Bell telephone company, envisioned 
communication in terms of information transmission from source to receiver, with the 
aim to analyse and improve the accuracy of this transmission periled by entropy and 
noise. Kay (Kay, 2000) chronicled how the interpersonal and institutional 
connections between Shannon and his co-author Warren Weaver and the early 
geneticists in the Rockefeller Foundation facilitated the transfer of the transmission 
model from communication to life sciences.  
 
The central dogma has been criticised for overplaying the role of genes as the origin 
of life processes (Keller, 2009). Moss has argued that the idea that genes predict the 
development of disease applies to rare monogenic conditions, such as Huntington’s 
chorea, but tends to get conflated with the vast majority of diseases, which are 
polygenic, caused by complex interactions between environmental factors and genes 
(Moss, 2004). Shannon’s model of communication in terms of linear transmission 
was also discredited for envisioning audiences as passive recipients (Hall, 1980). As 
of late, research has argued that current Web 2.0 technologies, such as Wikipedia, 
have ushered a more participatory communication, where all users can take part in 
knowledge creation and dissemination (O'Reilly, 2007).  
 
The metaphor of genes as blueprint has, however, persevered and was still mostly 
used in scientific and media reporting on the Human Genome Project, even if 
scientists found that the human genome had surprisingly few genes, raising doubts 
about whether single genes could contain the programs for traits (Nerlich & Hellsten, 
2004). New scientific developments, such as epigenetics, have complicated the 
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central dogma and metaphors associated with it. Landecker and Panofsky (2013) 
have argued that epigenetics represents a more sociological understanding of 
genes, as it is interested in how social forces (pollution, nutrition, mothering) affect 
gene expression. Stelmach and Nehrlich (Stelmach & Nerlich, 2015), indeed, 
observed that UK media coverage of epigenetics came up with new metaphors, such 
as framing genes as “switches,” which could be turned on and off, and in terms of 
music, where epigenetic processes “played” genes differently. 
 
When closely reading the 23andMe’s website and interviews with its co-founder 
Anne Wojcicki, I noticed that genes were often referred to as data, raw data and 
being abundant; often genes were cast as data by the use of verbs, so genes were 
browsed, googled, uploaded, retrieved, collected and crowdsourced. Thus, genes 
were not represented as information or a code to be deciphered or cracked by 
scientists but cast as abundant natural or raw digital resource that could be 
searched, analysed and pooled for different purposes by scientists, lay customers 
and companies. These references to abundant, raw data that could be analysed by 
everyone for correlations, repeated key premises of the emergent discourse on big 
data (Kitchin, 2014). 
 
A methodological point is due here. Most research on genes and metaphors refer to 
what Lakoff and Johnson call conceptual metaphors -- so genes are like a book 
(Lakoff & Johnson, 2008). Understanding genes in terms of information transmission 
or big data are not necessarily conceptual metaphors. Information transmission can 
be seen as a historical discourse (Kay, 2000), but information transmission and big 
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data can also be defined as ontological metaphors, which seek to render a vague 
phenomenon or experience a discrete object that has specific aspects, can be 
referred to and possibly quantified, reasoned and acted upon (Lakoff & Johnson, 
2008).  
 
The nature and implications of the information transmission metaphor are well 
rehearsed in terms of leading to a gene-centric understanding of human behaviour 
and health (Keller, 2009). Big data, however, is an emergent concept with alleged 
ontological characteristics. Social scientists have identified and critically examined 
key alleged aspects of big data. The first aspect of big data resonates with the 
colloquial meaning of data as “facts and statistics collected together for reference or 
analysis” (Oxford Living Dictionaries, 2016), which implies data are raw material from 
which analyses or interpretations can be made. The promise of big data is argued to 
be that digital devices enable the collection of previously unforeseen quantities of 
naturally occurring data, such as clicks, which are not marred by researcher bias 
(Kitchin, 2014).  Second, big data supposedly renders theories obsolete, as the 
sheer quantity of data can reveal correlations, which emerge straight out of data 
(Kitchin, 2014; Ruppert, Law, & Savage, 2013). This aspect of big data is 
encapsulated in the slogan “correlation is everything” proclaimed by Chris Anderson, 
former editor in chief at Wired magazine (Anderson, 2008), and big data is seen as 
capable of revealing surprising correlations between diverse or heterogenous data 
(Kitchin, 2014; Ruppert et al., 2013). The third alleged feature of big data are that it 
can be interpreted by anyone with tools available online, yielding to multiple 
interpretations (Ruppert et al., 2013). 
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Lakoff and Johnson note that ontological metaphors do not seem metaphors at all, 
rather the aspects of the phenomenon simply seem like its natural or self-evident 
qualities (Lakoff & Johnson, 2008). So, it seems as if genes simply code for traits or 
constitute big data to be browsed for insights and correlations by whomever.  The 
way in which ontological metaphors naturalise certain qualities of a phenomenon 
render them close to what Barthes calls myth, a second order of signification, where 
connotations and denotations cohere around a core belief system or ideology 
(Barthes, 1972), and big data has been argued to have qualities of myth (Boyd & 
Crawford, 2012) and ideology (Van Dijck, 2014).  
 
However, metaphors and ideologies are not uncontested. Recent research on 
23andMe has pointed out how the company mobilises the rhetoric of sharing, open 
access and gift to legitimise extracting DNA and survey data from customers to be 
sold for private gain (Harris, Kelly, & Wyatt, 2016; Van Dijck & Poell, 2016). 
O’Riordan has noted how 23andMe frames its customers as publics who read and 
write about their genomes, whilst obfuscating how the focus on DNA constrain these 
practices (O'Riordan, 2013), and Kragh-Furbo and Tutton have observed how the 
company has turned customers’ saliva into a promissory substance, which is easy to 
circulate in the bioeconomy (Kragh-Furbo & Tutton, 2017). I agree with the 
observations of these authors. My contribution to this on-going scholarly discussion 
is to contextualise the rhetoric used by 23andMe within the body of literature on 
genes and metaphors as well as in the history of DTC genetic testing in the past 17 
years. This contextualisation allows me to pinpoint continuities between the two 
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apparently quite different companies in that the way in which both of them 
represented genes was underpinned by the metaphor of transmission of information, 
whereby genes code for risk of disease, which can be deciphered by scientists and 
mitigated by lifestyle change or targeted drugs. However, 23andMe also mobilised 
the metaphor of big data to render genes a natural or raw digital resource, which 
could be circulated, shared and taken up by devices across numerous sites 
transcending institutional boundaries (Ruppert et al., 2013) to legitimise its 
construction of a private biobank with over a million DNA samples and customers. 
The analysis that follows will show how the metaphors used by the two companies to 
make sense of genes and their relationships with their customers are -- confusingly 
enough -- both fundamentally similar and fundamentally different. 
 
Methods 
This article derives from a larger project, which started in 2006 and examined the 
marketing and regulation of nutrigenetic testing companies (Saukko, Reed, Britten, & 
Hogarth, 2010). The project expanded to include the 23andMe’s personal genome 
service in 2008.  
Sciona and 23andMe 
I chose to focus on Sciona, as it was the first DTC genetic testing company in the UK 
and was the foci of regulatory debates both in the UK and later in USA. The 
company was established in 2000 in London, moved to USA in 2004 and ceased to 
exist in 2009. Sciona sold nutrigenetic tests for a limited number of gene variants, 
purportedly associated with diet, and offered genetically tailored advice on nutrition 
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and micronutrients. The tests were mostly sold online, but the results and advice 
were communicated through a brochure sent to customers by post. Sciona was 
criticised for making scientifically invalid predictions and discussed by regulatory 
bodies, including the UK Human Genetics Commission (Human Genetics 
Commission, 2003) and the US Government Accountability Office (US Government 
Accountability Office, 2006). 
 
23andMe was founded in 2006 by Linda Avey and Anne Wojcicki, ex-wife of Sergey 
Brin, founder of Google. The company offered a “personal genome service” (PGS), 
and due to the development of increasingly efficient microarray technologies (Baker, 
2013) was able test for a large variety of genes (a total of 254 in 2013—as counted 
from the test itself), associated with health, traits, drug response and ancestry. 
23andMe also sold its test online and uploaded the results onto an interactive 
platform. From the start 23andMe invited its customers to take part in research and 
sold customers’ DNA and survey responses to researchers and private companies. 
In 2015 23andMe announced that it had genotyped a million customers (23andMe, 
2015). 
 
23andMe was also criticised by the GAO (US Government Accountability Office, 
2010), and in 2013 the US Food and Drug Administration (FDA) banned 23andMe 
from selling health-related tests for failing to provide evidence to support its 
marketing claims (Food and Drug Administration, 2013). After the ban the company 
continued to sell ancestry tests and what it termed raw data, a selection of 
genotyped single nucleotide polymorphisms (SNPs or ‘letter changes’), which 
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customers could upload onto online workaround software, such as Promethease, 
which linked the SNPs to disease risks.  
 
In 2014 23andMe launched a revamped health-related genetic test in the UK and 
Canada for being a carrier for a selection monogenic diseases and for some 
polygenic “risk factors.” In 2015 23andMe relaunched FDA approved health-related 
genetic tests in the USA for being a carrier for certain monogenic diseases. In 2017 
the company gained FDA approval for tests for ten polygenic risk factors. 
 
Material and Analysis 
The material analysed consists of old webpages of Sciona, which we retrieved using 
the Wayback Machine in 2006 in addition to saving the 2006-2008 webpages as 
pdf’s. We also purchased the Sciona test in 2006 and received a 86-page brochure 
containing the results and advice. We purchased the 23andMe US/UK test in 2008 
and bought the UK test in 2015, which gave access to two different sets of online 
test results and associated interactive features, which both remained active as of 
2017; the US test bought in 2008 remained largely unchanged since 2013, when 
FDA banned the test, whereas the features incorporated into the UK test have 
slightly changed between 2015 and 2017. We also uploaded the UK test results onto 
Promethease in 2015 and received a report. The material analysed include the 
Sciona websites 2001-2008, the 23andMe online results 2008 and 2015 and the 
Sciona (2006) and Promethease (2015) reports. 
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This material was complemented with a small selection of media articles. I focused 
on UK media coverage, as the tests were bought from the UK, and I searched the 
Lexis Nexis database for articles on the two companies in national newspapers. The 
database identified 34 articles on Sciona and 435 on 23andMe, and I chose to 
analyse a small selection of articles covering key moments in the companies’ 
lifespans. I selected the one and only article published when Sciona was launched in 
2001 and four from 2003 when the company was scrutinised by the Human Genetics 
Commission. Again, I selected the one and only article covering 23andMe’s launch in 
2007in USA, nine articles from 2014 when the company launched its test in the UK 
and nine articles focusing on research supported by 23andMe on skin ageing and 
depression between 2015 and 2017. I also analysed an article from 2013 in MIT 
Technology Review on Promethease and two interviews with Anne Wojcicki in 
PLosGenetics and tech magazine Inc. published in 2015 when the company gained 
its first FDA approval. The sample does not seek to be representative of the media 
coverage of the companies, it simply complements the main analysis of the websites 
and genetic test results by instances where public media and the company 
representatives describe, criticise, defend or market the tests at key points. 
 
I initially started doing a thematic analysis of the websites of the two companies to 
ascertain similarities and differences. This is when I noted the metaphors of 
information transmission and big data that repeated in the material, which refocused 
my analysis. The analysis was inductive, initially following the constant comparative 
method (Glaser, 1965); as mentioned I first read the websites and identified how the 
ontological metaphors (Lakoff & Johnson, 2008) of information transmission and big 
data repeated. I then read the material and literature on information transmission and 
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big data back and forth, highlighting instances were the two metaphors were 
articulated in the text in relation to genes and communication between the company 
and its customers. 
 
In what follows I will first analyse how Sciona’s website, results and media coverage 
represented genes and communication between the company and its customers 
through the metaphor of information transmission. Second, I will analyse how the 
23andMe website and media coverage and Promethease report articulated the 
metaphors of information transmission and big data. I will focus on how the metaphor 
of big data was articulated through (i) representing genes as data, (ii) casting genes 
as data correlated with diverse other data and (iii) the way in genetic data was 
represented as analysed by diverse actors from lay customers to other companies 
and software. 
 
Sciona and Information Transmission 
 
On an early version of its website in March 2001 Sciona’s described genes as 
“governing” metabolism: 
 
“…your genes govern how your metabolic pathways digest and dispose of 
nutrients and toxins within your body (Sciona, 2001) 
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This idea of genes as governing metabolism was translated into nutritional advice in 
the test results. So, customers were encouraged to adjust their diet to offset any 
defects in their genes. This is illustrated by the recommendations given based on the 
test results for six genes associated with “detoxification” in the customer report we 
received from Sciona in 2006: 
 
“You have variations in your genes important for antioxidant defences which 
may lead to less efficient removal of free radical damage from your body. … 
Increase your consumption of foods high in antioxidants such as vitamins A, C 
and E.” 
 
Thus, on Sciona’s website genes were cast as “governing” metabolism, implying the 
idea that genes code for beneficial or harmful traits, such as more or less efficient 
removal of free radicals, which could be offset by taking specific micronutrients. 
 
The news report on Sciona’s launch represented genes as “responsible for 
everything,” including “diseases you are susceptible to” (Cooke, 2001). The article 
went on to describe how in the test “your DNA is checked to see if your genes have 
adapted to cope with a certain diet,” continuing that if “your distant ancestors were 
Eskimos” you might “need to eat more oily fish” (Cooke, 2001). In this media report 
genes were cast particularly deterministically (being “responsible for” disease) and 
evolution was evoked to tell a story of how variations in genes related to diet were 
due to adaptation and, therefore, we should eat the diet of our ancestors. 
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The metaphor of information transmission also shaped how Sciona envisioned 
communication about nutrigenetics. In March 2001 the company presented itself as 
seeking to educate its customers and to ensure the faithful transmission of accurate 
scientific knowledge: 
 
“ … because much of the science and be impenetrable to the layperson and 
the debates sensationalist. The service will include a publishing component 
that educates the market by providing access to the underlying scientific 
principles, research and trials.” 
 
In these early texts Sciona adopted a fairly paternalistic view of its customers as 
needing educating by the company. This understanding was reinforced by, for 
example, an extensive “glossary” of scientific terms, such as “polymorphism,” related 
to genetics included in the webpages.  
 
The gist of Sciona’s marketing was that its genetics based nutritional advice would 
“motivate” behaviour change, undergirded by the psychological version of the 
transmission metaphor: stimulus (genetic risk information) triggering response 
(behaviour change). As illustrated on its question and answer section in 2004: 
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“… the people who will find the Sciona service of considerable value are those 
who need an extra bit of motivation to maintain healthy habits or those who 
find it easier and more realistic to focus on areas particularly important for 
them …” 
 
Further, the notion of genes and communication in terms of information transmission 
not only informed symbolic metaphors in marketing and regulatory texts but also the 
material structure of Sciona’s digital platform. The company’s website offered 
information for its customers and the test results were sent directly to them. The 
website had no interactive features that would allow customers to give feedback, 
have a conversation or tinker with their genetic results or data. The Sciona website, 
thus, conformed to what has been termed Web 1.0 design, predicated on 
transmitting authoritative information from sender to receiver (O'Reilly, 2007). 
 
Starting in 2002 and particularly in 2003 Sciona came under attack from the UK 
Human Genetics Commission for selling tests that were not scientifically valid. Media 
reporting of these debates used the metaphor of “health horoscopes” (Barnett, 2003; 
Thornton, 2003) to describe the tests, evoking the domain of superstition, so that the 
tests were not associated with scientific predictions of future but illegitimate fortune 
telling. A news report lamented that “I thought I could find out if I had an obesity or 
depression gene” but “all I got was healthy eating advice” (Thornton, 2003), whereas 
another news article debated the “ethics” of knowing “how you will die and when,” 
referring to the tests as “genetic time bombs” (Barnett, 2003). Whilst both news 
reports evoked critical metaphors of horoscopes and time bomb in relation to genes, 
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they still confirmed the underlying ontological metaphor of genes as transmitting 
information, just communicating disappointment that the nutrigenetic tests did not 
live up to this ideal or that such predictions might raise ethical issues. 
 
Browsing Genes 
23andMe’s website and its media coverage frequently cast genes in a different way 
as data, using verbs such as browse, explore, search or google. This was illustrated 
by the only UK piece of news in the Lexis-Nexis database on 23andMe’s launch (in 
the USA) in 2007, which was titled “Search engine aims to Google your genes” and 
reported: 
 
Google has expanded its mission to lay bare the world’s information by 
investing in a company set up by its co-founder’s wife that lets users trawl 
their genetic profile online (Blakeley, 2007) 
 
In this article genes were something that could be digitally searched (googled) or 
fished with a net (trawled), implying genes were bits of data or a natural resource, 
which could be explored. Furthermore, the article implied that the data or resource 
could be exploited, referring to Google “laying bare” this information and googling 
customers’ genes, hinting at invading and making profit out of private data. Similarly, 
the reference to “online genetic profiles” played with the association between genetic 
profiles and social media profiles associating genes with the domain of the digital. 
16 
 
This idea of genes as a digital resource to be explored and exploited mapped onto 
the discourse and debates on big data (Kitchin, 2014). 
 
23andMe’s website represented genes as data most explicitly in the sections 
encouraging customers to analyse their “genome.” The company offered its 
customers what it described as “raw data” or “uninterpreted raw genotype data, 
including data that is not used in 23andMe reports,” which referred to single 
nucleotide polymorphisms (SNPs) identified by the company’s microarray. The 
references to “raw” and “uninterpreted” made the data seem unprocessed or natural, 
harking back to the alleged premise of big data as being naturally occurring and, 
thus, free of researcher bias (Ruppert et al., 2013).  
 
Throughout the 23andMe website the company used verbs, such as “navigate,” 
“browse,” “upload,” “share” and “compare,” in conjunction with genes, representing 
them as data. Similarly, the Promethease software described itself as a service to 
“retrieve” information about the genome. Metaphors typically operate across 
domains (Lakoff & Johnson, 2008; Nerlich & Hellsten, 2004), and the verbs used 
illustrated the way in which genes were likened not to information (Kay, 2000) but to 
digital data. Whereas information is typically interpreted as having one accurate 
meaning to be deciphered by experts, digital data is cast as dispersed or “circulated, 
shared and taken up by devices and across numerous websites” (Ruppert et al., 
2013). This rhetorical move, casting genes as mobile, digital data legitimised and 
reflected the way in which 23andMe moved customer DNA out of the laboratory and 
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the clinic to be circulated, shared and traded in the digital domain to enable its dual 
business model of consumer genetics and live private biobank. 
 
However, in other parts of 23andme’s website the representation of genes was 
underpinned by the classic, deterministic information transmission metaphor, the 
genetic risk profiles of 2008 stating that “your test results indicate you are at 
increased risk for atrial fibrillation based on genetics” and adding that “the heritability 
of atrial fibrillation is estimated to be 62%.” However, the risk profile for lung cancer 
estimated its “heritability” to be 8-14%, continuing that “environmental factors,” such 
as smoking, contributed “more to differences in risk than genetic factors.” In these 
cases genes were represented as playing a bigger (62%) or smaller (8-14%) role in 
causing polygenic disease, together with environmental factors. Nevertheless, even 
if the role of genes was estimated to vary, genes were still cast as coding for 
disease, which could be prevented with lifestyle changes (quitting smoking). 
 
Understanding genes in terms of information transmission was also evident in the 
coverage of the 2014 UK launch of 23andMe’s health-related tests. The Sun 
reported how the test let users  
 
… have their DNA screened for genes associated with inherited conditions, 
such as Alzheimer’s, cancer or diabetes. Kits claim to reveal which conditions 
you are likely to develop (Earle & Quinton, 2014). 
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In this instance genes were “screened,” which implied expert, medical knowledge, 
which “revealed” whether an individual will develop cancer or Alzheimer’s. The idea 
of genes revealing your destiny repeated the same notion of genes containing the 
code, which determined future, as discussed in previous research (Nelkin, 1994). 
However, in another piece of news of the same launch the tests were described to 
“allow users to both browse the raw code of their genome and use tools to 
investigate their genetic makeup” (Gibbs, 2014), again representing genes as digital 
data to be explored. 
 
Overall, 23andMe’s website and media coverage shifted between describing genes 
through the ontological metaphors of information and big data. Representing genes 
as digital data to be browsed bestowed them with qualities of being uninterpreted or 
raw, which obfuscated the fact that no data is ever raw but always curated (Bowker, 
2000), which has been discussed in relation to the big data discourse (Kitchin, 2014). 
In the case of 23andMe this curating was exactly what the company sold, turning 
saliva into SNPs using a specific microarray technology. Thus whilst the use of 
verbs, such as browsing, gave a sense of limitless exploration, it was restricted to 
investigating a digital dataset containing a list of selected SNPs, which obviously was 
a very limited and specific lens through which to explore health, as has been 
observed (O'Riordan, 2013).  
 
Furthermore, and perhaps more importantly, when genes were described as digital 
big data or resource they could be moved around, downloaded, uploaded, retrieved, 
navigated, pooled and shared. This rhetorical move legitimated the collection of 
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customers’ DNA to be sold on to researchers and commercial companies, as genes 
were represented as a digital resource circulated to facilitate discovery by lay users 
and commercial partners alike rather than being a fateful code cracked by scientists 
in a laboratory. 
 
Genes and Correlations 
 
Another key feature of the discourse on big data is the idea that its sheer volume 
enables the correlation of diverse or heterogenous data, facilitating new discoveries 
and insights (Kitchin, 2014). 23andMe’s platform fostered viewing genes as data that 
could be correlated with other forms of data; this view was not only communicated 
through text but also by the way in which the platform was structured. 
 
Prior to the FDA ban in 2013 23andMe offered its customers “genetic risk profiles,” 
which synthesized information from several gene variants. Thus, a customer could 
be told they were at an “increased” genetic risk for a specific health condition, such 
as type 2 diabetes. 23andMe did not offer preventive advice directly based on the 
risk profiles (i.e. based on your genes you should eat this or avoid that). Rather, next 
to the profiles the company linked to “resources,” which would lead to organisations, 
such as American Heart Association, offering information on the disease, risks and 
prevention. Thus, the genetic risk profile for type 2 diabetes would link to a BMI 
calculator, family history tool and various diabetes risk calculators, which would 
calculate users’ risk based on questionnaires on e.g. waist circumference or 
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consumption of simple carbohydrates as well as offer preventive advice. These links 
invited customers to correlate their genetic test results with their BMI, family history 
and so on. 
 
The polygenic risk profiles were withdrawn after the FDA ban in 2013. However, the 
company continued to offer links to similar resources and other data in conjunction 
with the genetic risk factors in the UK 2015 test. Further, customers could continue 
to get information on the associations between their gene variants and alleged 
susceptibility for many different diseases by uploading their raw data onto software, 
such as Promethease, which explicitly described itself as linking data or “connecting 
a file of DNA genotypes to scientific findings cited in SNPedia” (an open access 
database containing SNPs). The Promethease report linked individual gene variants 
to multiple conditions and traits. For example, the gene variant rs1800497 was linked 
to avoidance of errors, ADHD, alcohol dependency, postoperative nausea, obesity 
and effectiveness of a smoking cessation drug (Buprion). Similarly, conditions were 
linked to multiple genes; so that one could find multiple genes associated with 
bipolar disorder, and the report also described possible gene interactions. Thus, 
Promethease did not envision a single gene coding for a single trait. Rather, the 
service cast genes as part of a complex, even confusing, cluster of data, where 
multiple disparate conditions were associated with multiple genes and vice versa. 
 
The way in which customers were invited to participate in research on the 23andMe 
website also encouraged thinking about associations between genes and other data. 
On the front page after login on the 2015 UK platform customers were asked to 
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answer short questions for research, such as whether one is a morning person or a 
night person or how close one lives to a farm or an industrial plant. These questions 
insinuated that there was a potential association between one’s genes and being a 
morning person or living close to farms or factories. 
 
In 2017 “featured content” appeared on the front page of the 2008 account, 
combining the customer’s genetic test results (“Your genes put you at lower risk for 
migraines”) and her responses to research surveys (“YOU SAID I have not had 
migraines”) as well as survey data from CureTogether -- a platform for people with 
chronic conditions crowdsourcing data to find cures and acquired by 23andMe in 
2012 to source phenotypic data (Empson, 2012). The section described how “we 
tapped the wisdom” of “the CureTogether community” and identified triggers (stress 
85%, alcohol 42%, bananas 6% etc.) and treatments (Tylenol®, dark room, wet 
towel around your head etc.) for migraines, continuing that “symptom data and 
treatment data” can “powerfully” reveal that those who “experienced dizziness with 
their migraines were three times more likely to have a negative reaction to Imitrex®.” 
So, the juxtaposition of genetic test results, one’s own survey answers and 
crowdsourced data on symptoms, triggers and treatments for migraine created a 
sense of it being possible to gain “powerful” insights on, for example, drug response, 
by correlating these different data. 
 
The same idea of finding new insights by correlating genetic and survey data 
occurred in the media coverage of research using 23andMe’s data. For example, a 
study funded by Olay (a cosmetics brand owned by Procter & Gamble) on skin 
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ageing was reported to have found out that “secret” of “ageing well” was “down to 
lifestyle,” noting that genetics can “give you a head start” but other factors that 
“really” “shape how you look” included taking a multivitamin, sleep and using a 
moisturiser (Allen, 2017). Another study, funded by Pfizer, on depression was 
reported to have found “17 genetic variations that raise the risk of depression” and 
could possibly “lead to new treatments.” The article also noted that each genetic 
variant contributed only to a “minuscule” increase in the risk and so “huge sample 
sizes” were needed to “spot” them, highlighting “the value of data from genetics 
companies” (Davis, 2016). 
 
These news reports did not represent genes deterministically but described genes as 
playing only a small role in skin ageing or development of depression, which led the 
other article to rehash the discourse on big data referring to how “huge” quantities of 
data was needed to “spot” these “minuscule” risks. However, genes were still seen 
through the metaphor of information transmission, as they were represented as 
coding for risk, even if small. The more important thing, however, was the way in 
which the data brought to bear on skin ageing and depression dovetailed the 
commercial interests of the funders, illustrating how moisturisers help with youthful 
looks or pinpointing genetic variants that might aid in the development of new 
antidepressants in the potentially commercially lucrative situation where more than 1 
in 10 Americans are taking medications for depression but the development of new 
drugs has stalled since the invention of selective serotonin reuptake inhibitors in the 
1980s (Block, 2015; Centers for Disease Control and Prevention, 2011). 
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Overall, 23andMe often cast genes through the ontological metaphor of big data, 
whereby they were seen as one data among many, and where correlation is 
everything (Anderson, 2008). The juxtaposition or correlation of different data that 
allegedly contributed to health and illness -- from genes to waist circumference, dark 
rooms and use of moisturiser -- created an impression of diverse data and surprising 
correlations born “straight out of data” (Kitchin, 2014; Ruppert et al., 2013).  
 
However, even if genes were cast as part of heterogenous big data they were not 
seen through the epigenetic metaphors (Stelmach & Nerlich, 2015) as modifiable by 
environmental triggers. Rather, genes were represented through the information 
metaphor as coding for (smaller or bigger) risk for disease or other trait, such as 
premature skin ageing. This representation of genes was essentially not much 
different from Sciona’s view of them as coding for risk for lifestyle-related diseases. 
 
Perhaps more importantly, although the data correlated with genetic data appeared 
diverse, it mostly focused on individual behaviour or indicators typically associated 
with such behaviour, such as waist circumference, stress, sufficient sleep and 
alcohol consumption. The data collected in the commercially funded studies also 
reflected the funders’ interests, such as including data on use of cosmetics or 
seeking to aid in the development of pharmaceuticals. The way in which 23andMe 
represented genes as big data to be correlated with limitless plurality of other data 
obfuscated the narrow, commercially informed range of data collected and 
correlated. 
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Multiple Interpretations 
Following from above, another key aspect of the discourse on big data is the idea 
that the vast amounts of data becoming available online can be analyzed by anyone 
with digital devices (Ruppert et al., 2013). Thus, the way in which communication 
between 23andMe and its customers was represented through the ontological 
metaphor of big data implied that genetic data could be analyzed by a wide variety of 
actors, yielding multiple interpretations. 
 
The 23andMe platform provided its customers many such “digital devices” to enable 
them to analyse their genetic data. The platform enabled customers to “connect” with 
alleged “relatives” and “share” and “compare” “genomes” with them, and early on 
news coverage noted that the company “echo the style of social-networking sites” 
(Blakeley, 2007). The ability to upload one’s raw data enabled customers to analyze 
or compare their SNPs alone or together. It was commonplace in the 23andMe user 
fora for customers to solicit others to share their SNP data and disease data to 
search for correlations to corroborate putative theories of specific genes being 
associated with disease, mimicking the company’s research.  
 
However, on other sections of the platform 23andMe articulated its relationship with 
its customers in terms of accurate information transmission. The genetic test results 
included illustrative graphs on relative risk and the ‘Genetics 101’ video on the front 
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page of the website both conforming to the ideal of accurate information 
transmission from experts to lay customers. 
 
Further, 23andMe enabled its customer not only to explore or browse their raw data 
on its website but also to upload it onto other software. MIT Technology Review 
article on one of the software, Promethease, noted that “DNA information is 
essentially digital. That means it can plug and play anywhere” (Regalado, 2014); the 
same idea was espoused by Wojcicki in a PLos Genetics interview: 
 
We have an API [Application Program Interface], a standard tool in the tech 
world to enable people to pull down their data. That way, Promethease and all 
these others can build tools on top of the infrastructure that we have. We try 
to encourage use for art or music or other things that we just aren’t doing. It’s 
your data—you can do all kinds of things—explore it! We want to foster that 
industry of others bringing your data to life in ways we don’t, and we’ve had 
other research groups use data form medical information (directly from our 
clients)” (Gitschier, 2015). 
 
The software customers could use to “plug and play” their raw data included services 
which interpreted associations between gene variants and disease susceptibility 
(Promethease, Interpretome), turned the raw data into music (DNAMelody) or for 
nutritional advice (NutraHack) and tracked potential relatives through comparing 
DNA (GEDMatch), just to name a few. Whereas the metaphor of information 
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insinuated that there was one accurate expert interpretation of genes, the metaphor 
of big data cast DNA as open for multiple interpretations or to be “played” or “brought 
into life” differently. The musical metaphor of “playing” DNA differently has been 
observed to be used in epigenetics (Stelmach & Nerlich, 2015), however, in this 
instance it was not nature or environmental triggers but software that was “playing” 
DNA differently; the latter metaphor implied that data was dead or inert until it was 
brought to life by software, further imputed it with powers of vitality and creativity. 
 
Further, 23andMe envisioned genetic data as part of a broader discourse on digital 
health or Quantified Self (Ruckenstein & Pantzar, 2015), whereby individuals 
continuously collect, store and analyse a variety of data on themselves, as explained 
by Wojcicki: 
 
Your health care is no longer about the episodic visit to your doctor, where 
you have this once-a-year assessment of random vitals," she says. "It's about 
the continuous stream of you.(Bercovici, 2015). 
 
This interview projected a future vision, whereby doctors had been surpassed as 
providers of health knowledge, and individuals, streaming data, using digital devices, 
to monitor their health. 
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This vision of self-monitoring and data collection for health also folded back onto 
23andMe’s goal of collecting and trading customers’ DNA and survey data. In 2017 a 
vignette appeared on top of the genetic test results, stating “23andMe Research 
Discoveries were made possible by 23andMe members who took surveys,” implying 
that by answering the surveys (available by clicking on the vignette) customers could 
add to the “discoveries” making up the results (even if these were based on scientific 
research on genetic associations published worldwide). Similarly, the feature 
combining customer’s genetic test results, survey answers and the CureTogether 
crowdsourced data on migraines invited customers to contribute to the CureTogether 
database and 23andMe research. Thus, customers and the company were 
represented as jointly creating, streaming or “crowdsourcing” diverse data, which 
could directly enable individuals to know more about themselves; this has been 
noted by Prainsack and Tutton (Tutton & Prainsack, 2011), who have observed that 
23andMe invited its customers to take part in research not for altruistic but for 
“entrepreneurial” reasons to gain knowledge about themselves. 
 
Overall, imagining the communication between 23andMe and its customers through 
the ontological metaphor of big data represented them jointly producing and 
analysing data with the aid of diverse software, yielding multiple interpretations. 
However, as has been noted, the promise of big data as being analysable by 
everyone is hollow, as companies, such as Google or Procter & Gamble, have 
privileged access to the big data sets and the computational skills to analyse them 
(Boyd & Crawford, 2012). Lay consumers can analyse their genetic and other data; 
yet their explorations are constrained by the platforms, data and software made 
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available to them mainly by 23andMe and other companies to encourage them to 
consume the services and to produce data to be sold on. 
 
Discussion 
 
Sciona  - one of the first DTC genetic testing companies – represented genes 
through the classical metaphor of information as coding for lifestyle related diseases 
and transmitting this expert knowledge to consumers so that they could offset any 
deficiencies in their genetic make-up with specific foods and supplements.  
 
23andMe’s website and its media coverage also evoked the metaphor of information 
to represent and communicate about genetic risk factors. However, the company 
and media also cast genes and the relationship between the company and its 
customers through the novel ontological metaphor of big data. So, genes were 
represented as an abundant resource, which could be browsed and correlated with 
diverse other data to reveal new insights. Further, in keeping with the big data 
discourse (Kitchin, 2014) this browsing and correlating was represented as 
something that lay customers and scientists could both do. Representing DTC 
genetic testing through the ontological metaphor of big data gave a sense of limitless 
possibilities in terms of the amounts and diversity of data to be collected and 
correlated and the kinds of interpretations or insights to be yielded. Yet, on closer 
examination, the kinds of data correlated with 23andMe’s genetic data and the kinds 
of discoveries made highlighted that 23andMe’s tests and the research the company 
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supported still represented genes in terms of coding -- in a bigger or smaller way -- 
for illness or and wellness to be mitigated by lifestyle or targeted drugs.  
 
However, the ontological metaphor of big data was also different from the classical 
notion of genes as information. Metaphors operate cross domains (Lakoff & 
Johnson, 2008), and rendering genes digital big data transfers them from the closed, 
expert domains of the laboratory and the clinic into digital media, within which data 
can be moved about, interpreted, shared and traded by any user. The ontological 
metaphor of big data, thus, legitimised 23andMe’s business model, both in terms of 
selling genetic tests direct to consumers and customers’ DNA and other data to other 
companies, as genes were like any digital data to be browsed and shared. 
 
Research on metaphors and genes has often noted that the information metaphor 
leads to a deterministic notion of genes, as if containing the programme for life 
(Nelkin, 1994). Scholars have suggested that genes should be understood in more 
“contextual” manner, which would acknowledge that they interact with their 
biological, environmental and social context (Kay, 2000). Recent metaphors of genes 
as music or as part of an ecology identified in scientific and media coverage of 
epigenetics and the Human Microbiome (Nerlich & Hellsten, 2009; Stelmach & 
Nerlich, 2015) suggest that more interactive notions of genes are emerging. The way 
in which the ontological metaphor of big data was articulated on 23andMe’s website 
and media coverage did not, however, suggest that genes are influenced by other 
factors, even if other factors were acknowledged to play a role in determining 
wellness and illness. The metaphor of big data, thus, did not represent biological 
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processes or what genes “can do” (Moss, 2004) in a new way, but it represented 
social processes or what can be done with genes in a novel way by rendering them a 
digital resource to be circulated, shared and sold. 
  
Critical social scientists have observed that 23andMe mobilises concepts associated 
with the participatory or democratic potential of digital media, such as open source, 
being part of a community and sharing, to legitimise collecting customers’ DNA and 
other data to be sold for profit (Harris et al., 2016; O'Riordan, 2013; Van Dijck & 
Poell, 2016).  The analysis of how the company mobilised the metaphor of big data 
illustrates how 23andMe legitimised its operation by casting genes not as a special 
code to be cracked by the cognoscenti but as any digital data resource to be 
circulated among the many. 
 
In the end, policy conversations around DTC genetic testing have been underpinned 
by the information transmission metaphor seeking to guarantee the accuracy of the 
tests and that consumers accurately understand them (Food and Drug 
Administration, 2013). 23andMe, which has quickly become a major player in 
consumer genetics and private biobanking raises the possibility that these kinds of 
companies begin to not only influence the way in which lay customers perceive their 
health but also shape health research.  In this situation there is a danger that data --- 
such as data on social and environmental inequalities -- which does not fit the 
agenda of entrepreneurial individualism, biotech and profit making gets increasingly 
downplayed and ignored in preventive healthcare and research (Reardon, 2013). So, 
the political questions raised by 23andMe extend beyond consumer protection and 
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towards critical issues vis a vis health and data both highlighted and hidden (Lakoff & 
Johnson, 2008) by the ontological metaphor of big data: What kinds of data are 
considered important or become data in the first place? (Bowker, 2000). Whose data 
is being collected, who does the analytical and interpretive work that turns the data 
into legitimate knowledge and for what purpose? 
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